Isolated proximal greater saphenous vein thrombosis and the risk of propagation to deep vein thrombosis and pulmonary embolism. 2018

Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
Department of Emergency Medicine, William Beaumont Hospital, Royal Oak, MI, USA.

OBJECTIVE Greater saphenous vein (GSV) thrombosis is concerning due to its close proximity to the deep femoral vein. This study sought to identify the risk of propagation to deep vein thrombosis (DVT) or pulmonary embolism (PE) among patients with isolated proximal GSV superficial thrombosis and describe provider practice patterns related to treatment. METHODS This is an Institutional Review Board-approved retrospective multi-center study. Patients presented to one of three possible emergency departments in a large health system. About 21,716 patients were queried through the electronic medical record. Ninety-five patients or 0.4% of study subjects met inclusion criteria of isolated proximal GSV thrombosis. Forty-five patients were excluded, leaving a final data set of 40 patients. Investigators recorded radiology impressions, patient demographics, past medical history, DVT/PE risk factors, and treatment plans. Propagation of GSV thrombosis to DVT/PE was also noted. Follow-up methods included chart review, primary care physician follow-up, and direct, scripted patient follow-up phone calls. Descriptive statistics were applied to study subjects using SAS for Windows, version 9.3. RESULTS Three patients (7.5%) had progression of GSV thrombosis to DVT/PE. Twenty percent of patients without malignancy were treated with anticoagulation compared to 14% of those with preexisting malignancy upon initial diagnosis of isolated GSV thrombosis. Forty-five percent of patients were prescribed some type of supportive therapy to aid in the treatment of GSV thrombosis. CONCLUSIONS Isolated proximal GSV thrombosis, while uncommon, may frequently progress to DVT or PE. Our work suggests clinicians should consider anticoagulation for isolated GSV thrombosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
March 2016, Thrombosis and haemostasis,
Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
June 2022, Seminars in thrombosis and hemostasis,
Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
May 2012, Lancet (London, England),
Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
December 2016, Lancet (London, England),
Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
August 1993, Lancet (London, England),
Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
December 2019, La Revue du praticien,
Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
June 1980, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
November 2021, MMW Fortschritte der Medizin,
Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
February 2009, Circulation journal : official journal of the Japanese Circulation Society,
Samuel H Kim, and Nimesh Patel, and Kanika Thapar, and Ananda V Pandurangadu, and Amit Bahl
September 2013, The European respiratory journal,
Copied contents to your clipboard!